Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
24/08/2007 Xie Gan Wan Tablets - Traditional Chinese Medicinal Product Warning
22/08/2007 Salbutamol (Ventolin) with myocardial ischaemia - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board 3rd Party Publications
07/08/2007 Serdolect (sertindole) - Important Safety Information from Lundbeck (Ire) Ltd as approved by the Irish Medicines Board 3rd Party Publications
03/08/2007 Kaletra (lopinavir/ritonavir) - Important Safety Informationf from Abbott Laboratories as approved by the Irish Medicines Board 3rd Party Publications
01/08/2007 Botulinum Toxin 3rd Party Publications
27/07/2007 Acomplia (rimonabant) 20mg film-coated tablet - Important Safety Information from Sanofi Aventis as approved by the Irish Medicines Board 3rd Party Publications
19/07/2007 Acomplia must not be used inpatients on antidepressants or with major depression Warning
13/07/2007 Viracept (nelfinavir) - Important Safety Information from Roche as approved by the Irish Medicines Board 3rd Party Publications
03/07/2007 Botulinum Toxin Products - Botox, Dysport, NeuroBloc - Important Safety Information from Allergan as approved by the Irish Medicines Board 3rd Party Publications
01/07/2007 IMB Suspension of Marketing of Nimesulide containing medicines 3rd Party Publications